{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:24Z","timestamp":1789685004663,"version":"4.0.1"},"reference-count":27,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2017,3,4]]},"DOI":"10.1080\/14760584.2017.1244009","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T10:05:58Z","timestamp":1478253958000},"page":"273-287","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab')<sub>2<\/sub> fragments"],"prefix":"10.1080","volume":"16","author":[{"given":"Elisa","family":"Reveneau","sequence":"first","affiliation":[{"name":"Sanofi Pasteur, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cottin","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvar","family":"Rasuli","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00287-6"},{"key":"CIT0003","volume-title":"WHO expert consultation on rabies. Second report","author":"World Health Organization","year":"2013"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.14-6-78"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","volume":"9","author":"Hampson K","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"CIT0010","first-page":"747","volume":"13","author":"Baltazard M","year":"1955","journal-title":"Bull World Health Organ"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/jtm.12024"},{"key":"CIT0013","first-page":"309","volume":"32","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"CIT0014","first-page":"491","volume":"76","author":"Lang J","year":"1998","journal-title":"Bull World Health Organ"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(98)00038-2"},{"key":"CIT0016","volume-title":"Guideline on good pharmacovigilance practices (GVP). Module VI \u2013 management and reporting of adverse reactions to medicinal products","author":"European Medicines Agency","year":"2011"},{"key":"CIT0017","volume-title":"Guideline on good pharmacovigilance practices (GVP). Module I \u2013 pharmacovigilance systems and their quality systems","author":"European Medicines Agency","year":"2011"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000243"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.036"},{"key":"CIT0023","first-page":"15","author":"Quiambao B","year":"2008","journal-title":"APCRI J"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.064"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.030"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(89)90010-8"},{"key":"CIT0027","first-page":"1","volume":"52","author":"Zhou W","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M2232"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80007-6"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1007\/s13149-012-0223-3"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0750-7658(98)80105-6"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2012.660695"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.01.003"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.09.027"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.08.050"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1085142"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2017.1244009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T12:33:14Z","timestamp":1500553994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2017.1244009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,12,30]]},"published-print":{"date-parts":[[2017,3,4]]}},"alternative-id":["10.1080\/14760584.2017.1244009"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2017.1244009","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}